Dev Prasad
Stock Analyst at LUCID CAPITAL MARKETS
(2.77)
# 2,022
Out of 5,044 analysts
5
Total ratings
60%
Success rate
31.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dev Prasad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUE Cue Biopharma | Initiates: Buy | $4 | $0.74 | +442.37% | 1 | Aug 25, 2025 | |
| IRD Opus Genetics | Initiates: Buy | $5 | $1.93 | +159.07% | 1 | Jun 17, 2025 | |
| AVTX Avalo Therapeutics | Initiates: Buy | $24 | $18.38 | +30.58% | 1 | Dec 17, 2024 | |
| IBIO iBio, Inc. | Initiates: Buy | $6 | $1.39 | +331.65% | 1 | Dec 17, 2024 | |
| CALC CalciMedica | Initiates: Buy | $13 | $3.11 | +318.01% | 1 | Dec 17, 2024 |
Cue Biopharma
Aug 25, 2025
Initiates: Buy
Price Target: $4
Current: $0.74
Upside: +442.37%
Opus Genetics
Jun 17, 2025
Initiates: Buy
Price Target: $5
Current: $1.93
Upside: +159.07%
Avalo Therapeutics
Dec 17, 2024
Initiates: Buy
Price Target: $24
Current: $18.38
Upside: +30.58%
iBio, Inc.
Dec 17, 2024
Initiates: Buy
Price Target: $6
Current: $1.39
Upside: +331.65%
CalciMedica
Dec 17, 2024
Initiates: Buy
Price Target: $13
Current: $3.11
Upside: +318.01%